Interleukin-1β stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-β-dependent mechanism
Male
Antibodies/immunology/pharmacology
Pathogenesis
Collagen-synthesis
Kidney Cortex/cytology/*drug effects/metabolism
0302 clinical medicine
Nitric-oxide
Transforming Growth Factor beta
Enzyme Inhibitors
Extracellular Matrix Proteins/*drug effects/metabolism
Cells, Cultured
Enzyme Inhibitors/pharmacology
Extracellular Matrix Proteins
Cultured
Research & Experimental
Epithelial-cells
Tetradecanoylphorbol Acetate/pharmacology
3. Good health
Medical Laboratory Technology
Mesangial Cells
Medicine
Tetradecanoylphorbol Acetate
Female
Kinase-c
Drug
Interleukin-1/*pharmacology
Fibronectins/metabolism
Proximal Tubule Cells
Tumor-necrosis-factor
DNA Replication
Kidney Cortex
110312 Nephrology and Urology
DNA/biosynthesis
Cells
610
Collagen Type I/metabolism
General & Internal
Nitric Oxide
Fibroblasts/cytology/*drug effects/metabolism
Antibodies
Collagen Type I
Dose-Response Relationship
03 medical and health sciences
C1
Humans
Dose-Response Relationship, Drug
*Transforming Growth Factor beta/immunology/metabolism
DNA
Fibroblasts
DNA Replication/drug effects
Fibronectins
730118 Organs
diseases and abnormal conditions not elsewhere classified
Nitric Oxide/metabolism
Angiotensin-ii
Factor-alpha
Interleukin-1
DOI:
10.1067/mlc.2002.128468
Publication Date:
2002-12-03T12:41:52Z
AUTHORS (6)
ABSTRACT
One of the hallmarks of progressive renal disease is the development of tubulointerstitial fibrosis. This is frequently preceded by macrophage infiltration, raising the possibility that macrophages relay fibrogenic signals to resident tubulointerstitial cells. The aim of this study was to investigate the potentially fibrogenic role of interleukin-1beta (IL-1beta), a macrophage-derived inflammatory cytokine, on cortical fibroblasts (CFs). Primary cultures of human renal CFs were established and incubated for 24 hours in the presence or absence of IL-1beta. We found that IL-1beta significantly stimulated DNA synthesis (356.7% +/- 39% of control, P <.003), fibronectin secretion (261.8 +/- 11% of control, P <.005), collagen type 1 production, (release of procollagen type 1 C-terminal-peptide, 152.4% +/- 26% of control, P <.005), transforming growth factor-beta (TGF-beta) secretion (211% +/- 37% of control, P <.01), and nitric oxide (NO) production (342.8% +/- 69% of control, P <.002). TGF-beta (1 ng/mL) and the phorbol ester phorbol 12-myristate 13-acetate (PMA, 25 nmol/L) produced fibrogenic effects similar to those of IL-1beta. Neither a NO synthase inhibitor (N(G)-methyl-l-arginine, 1 mmol/L) nor a protein kinase C (PKC) inhibitor (bis-indolylmaleimide 1, 1 micromol/L) altered the enhanced level of fibronectin secretion or DNA synthesis seen in response to IL-1beta treatment. However, addition of a TGF-beta-neutralizing antibody significantly reduced IL-1beta-induced fibronectin secretion (IL-1beta + IgG, 262% +/- 72% vs IL-1beta + alphaTGF-beta 156% +/- 14%, P <.02), collagen type 1 production (IL-1beta + IgG, 176% +/- 28% vs IL-1beta + alphaTGF-beta, 120% +/- 14%, P <.005) and abrogated IL-1beta-induced DNA synthesis (245% +/- 49% vs 105% +/- 21%, P <.005). IL-1beta significantly stimulated CF DNA synthesis and production of fibronectin, collagen type 1, TGFbeta, and NO. The fibrogenic and proliferative action of IL-1beta on CF appears not to involve activation of PKC or production of NO but is at least partly TGFbeta-dependent.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (80)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....